Aerosol-generating procedures and infective risk to healthcare workers from SARS-CoV-2: the limits of the evidence.

Adult Aerosols Betacoronavirus COVID-19 Coronavirus Infections / diagnosis Female Health Personnel / statistics & numerical data Humans Infectious Disease Transmission, Patient-to-Professional / statistics & numerical data Male Middle Aged Occupational Exposure / statistics & numerical data Pandemics Pneumonia, Viral / diagnosis Risk Assessment / statistics & numerical data SARS-CoV-2
Aerosol-generating procedures Infectivity Nosocomial infection SARS-CoV-2 Transmission

Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 15 04 2020
accepted: 26 05 2020
pubmed: 5 6 2020
medline: 22 8 2020
entrez: 5 6 2020
Statut: ppublish

Résumé

The transmission behaviour of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is still being defined. It is likely that it is transmitted predominantly by droplets and direct contact and it is possible that there is at least opportunistic airborne transmission. In order to protect healthcare staff adequately it is necessary that we establish whether aerosol-generating procedures (AGPs) increase the risk of transmission of SARS-CoV-2. Where we do not have evidence relating to SARS-CoV-2, guidelines for safely conducting these procedures should consider the risk of transmitting related pathogens. Currently there is very little evidence detailing the transmission of SARS-CoV-2 associated with any specific procedures. Regarding AGPs and respiratory pathogens in general, there is still a large knowledge gap that will leave clinicians unsure of the risk to themselves when offering these procedures. This review aimed to summarize the evidence (and gaps in evidence) around AGPs and SARS-CoV-2.

Identifiants

DOI: 10.1016/j.jhin.2020.05.037 PMID: 32497651 PMC: PMC7263217
pubmed: 32497651
pii: S0195-6701(20)30277-2
doi: 10.1016/j.jhin.2020.05.037
pmc: PMC7263217
pii:
doi:

Substances chimiques

Aerosols 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

717-725

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Healthcare Infection Society. All rights reserved.

Références

J Hosp Infect. 2015 Nov;91(3):188-96
pubmed: 26452615
Public Health. 2017 Feb;143:103-108
pubmed: 28159021
Emerg Infect Dis. 2003 Oct;9(10):1205-10
pubmed: 14609453
Emerg Infect Dis. 2004 Feb;10(2):251-5
pubmed: 15030692
Ann Intern Med. 2020 Jun 2;172(11):766-767
pubmed: 32176257
Clin Infect Dis. 2007 Apr 15;44(8):1017-25
pubmed: 17366443
Health Technol Assess. 2010 Oct;14(46):131-172
pubmed: 20923611
Beijing Da Xue Xue Bao Yi Xue Ban. 2006 Jun 18;38(3):271-5
pubmed: 16778970
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
J Hosp Infect. 2020 Jun;105(2):119-127
pubmed: 32259546
Emerg Infect Dis. 2006 Nov;12(11):1657-62
pubmed: 17283614
Viruses. 2019 Oct 12;11(10):
pubmed: 31614743
J Med Virol. 2020 Jun;92(6):568-576
pubmed: 32134116
Chin Med Sci J. 2020 Feb 27;:
pubmed: 32102726
Emerg Infect Dis. 2004 Feb;10(2):287-93
pubmed: 15030699
Clin Infect Dis. 2017 Oct 15;65(8):1335-1341
pubmed: 29017249
N Engl J Med. 2003 May 15;348(20):1986-94
pubmed: 12682352
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Sep;25(9):741-4
pubmed: 15555351
Clin Med (Lond). 2020 Mar;20(2):124-127
pubmed: 32139372
Gastrointest Endosc. 2019 Apr;89(4):818-824
pubmed: 30391253
Ir J Med Sci. 2020 Mar 24;:
pubmed: 32212099
Eur Respir J. 2019 Apr 11;53(4):
pubmed: 30705129
N Engl J Med. 2004 Apr 22;350(17):1731-9
pubmed: 15102999
Emerg Infect Dis. 2004 Feb;10(2):358-63
pubmed: 15030713
Respirology. 2011 Aug;16(6):1005-13
pubmed: 21605275
Lancet Respir Med. 2020 Apr;8(4):e19
pubmed: 32105633
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
BMC Public Health. 2009 Mar 13;9:81
pubmed: 19284644
East Mediterr Health J. 2013;19 Suppl 1:S39-47
pubmed: 23888794
Epidemiol Infect. 2004 Oct;132(5):797-803
pubmed: 15473141
J Crit Care. 2012 Oct;27(5):434-9
pubmed: 22762937
Chest. 2004 Sep;126(3):845-50
pubmed: 15364765
J Hosp Infect. 2015 Apr;89(4):225-8
pubmed: 25578684
JAMA. 2020 Feb 24;:
pubmed: 32091533
PLoS One. 2013;8(2):e56278
pubmed: 23418548
PLoS One. 2010 May 19;5(5):e10717
pubmed: 20502660
Chin Med J (Engl). 2020 May 5;133(9):1109-1111
pubmed: 32097201
CMAJ. 2009 Nov 10;181(10):663-4
pubmed: 19825928
Respir Care. 2015 Jan;60(1):30-7
pubmed: 25316895
Br J Anaesth. 2003 Jun;90(6):715-8
pubmed: 12765882
Gastrointest Endosc. 2020 Jul;92(1):192-197
pubmed: 32179106
Emerg Infect Dis. 2004 Feb;10(2):269-76
pubmed: 15030696
Can J Anaesth. 2020 May;67(5):568-576
pubmed: 32052373
PLoS One. 2012;7(4):e35797
pubmed: 22563403
Eur Respir Rev. 2014 Dec;23(134):427-38
pubmed: 25445941
J Hosp Infect. 2020 Apr;104(4):534-537
pubmed: 31759093
Am J Respir Crit Care Med. 2004 Jun 1;169(11):1198-202
pubmed: 14990393
J Hosp Infect. 2020 May;105(1):100-101
pubmed: 32147406
Am J Infect Control. 2016 Dec 1;44(12):1634-1638
pubmed: 27388266
J Hosp Infect. 2019 Jan;101(1):84-87
pubmed: 30336170
Can J Anaesth. 2020 Jul;67(7):893-894
pubmed: 32189218
Chest. 2009 Oct;136(4):998-1005
pubmed: 19411297

Auteurs

H Harding (H)

Sunshine Coast Hospital and Health Service, Queensland, Australia. Electronic address: henry.harding@health.qld.gov.au.

A Broom (A)

School of Social and Political Sciences, The University of Sydney, New South Wales, Australia.

J Broom (J)

Sunshine Coast Health Institute, Queensland, Australia; University of Queensland, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Aerosol-generating procedures and infective...
questionsmedicales.fr › Préparations pharmaceutiques › Colloïdes › Aérosols › Aerosol-generating procedures and infective...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Aerosol-generating procedures and infective...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Aerosol-generating procedures and infective...
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Nidovirales › Infections à Coronaviridae › Infections à coronavirus › Aerosol-generating procedures and infective...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Personnel de santé › Aerosol-generating procedures and infective...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Aerosol-generating procedures and infective...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Transmission de maladie infectieuse › Transmission de maladie infectieuse du patient au professionnel de santé › Aerosol-generating procedures and infective...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Aerosol-generating procedures and infective...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pollution de l'environnement › Exposition environnementale › Exposition professionnelle › Aerosol-generating procedures and infective...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Aerosol-generating procedures and infective...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › Aerosol-generating procedures and infective...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Aerosol-generating procedures and infective...
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Aerosol-generating procedures and infective...